SCHEMBL30740978

SCHEMBL30740978

O=C(O)c1cc(OC(F)F)c(O)c([N+](=O)[O-])c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP6 P55212 1/20 0.49
TPMT P51580 1/20 0.48
TTR P02766 4/20 0.46
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
ALDH1A1 P00352 1/20 0.41
GPR35 Q9HC97 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA3 P07451 1/20 0.40
PKM P14618 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40
CA5A P35218 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
CA5B Q9Y2D0 1/20 0.40
ERN1 O75460 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30740968 0.85 TTR (0.49) TPMTTTRLMNAALDH1A1ERN1
SCHEMBL28259793 0.84 CASP6 (0.47) CASP6TPMTLMNATSHRALDH1A1
SCHEMBL31003858 0.81 CASP6 (0.63) CASP6TTRLMNATSHRHCAR3
SCHEMBL16974724 0.81 CASP6 (0.63) CASP6TTRLMNATSHRHCAR3
SCHEMBL16098843 0.81 CASP6 (0.63) CASP6TTRLMNATSHRHCAR3
SCHEMBL3583434 0.80 CA12 (0.66) CASP6TPMTTTRTSHRALDH1A1
SCHEMBL31447584 0.80 CA12 (0.66) CASP6TPMTTTRTSHRALDH1A1
SCHEMBL30740908 0.79 TPMT (0.48) CASP6TPMTTTRLMNATSHR
SCHEMBL503443 0.79 CASP6 (0.62) CASP6TPMTTTRLMNATSHR
SCHEMBL29222768 0.77 CASP6 (0.38) CASP6TPMTTTRLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed
EP-4561975-A1 FTO INHIBITORS RPXDS Co., Ltd (CN) 2025-06-04 EP disclosed
CN-119546566-A FTO inhibitors 瑞璞鑫(苏州)生物科技有限公司 2025-02-28 CN disclosed
WO-2024022491-A1 FTO INHIBITORS RPXDS CO., LTD (CN) 2024-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 CASP6 1454/4885TPMT 589/4885TTR 655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.